Hosted on MSN17h
Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround
A downtrend has been apparent in Artivion (AORT) lately with too much selling pressure. The stock has declined 18.6% over the ...
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts
It's been a mediocre week for Artivion, Inc. ( NYSE:AORT ) shareholders, with the stock dropping 13% to US$25.42 in ...
Artivion (NYSE:AORT) Shares Gap Down on Disappointing Earnings
Artivion, Inc. (NYSE:AORT – Get Free Report)’s stock price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $27.85, ...
Hosted on MSN3d
Artivion (NYSE:AORT) Misses Q4 Sales Targets
Medical device company Artivion (NYSE:AORT) in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s ...
Artivion sees 2025 revenue $420M-$435M, consensus $430.23M
Sees 2025 adjusted EBITDA growth of 18%-28%. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Artivion: Q4 Earnings Snapshot
The Kennesaw, Georgia-based company said it had a loss of 39 cents per share. Earnings, adjusted for one-time gains and costs, were less than 1 cent on a per-share basis. The biological medical device ...
Nasdaq1mon
Where Artivion Stands With Analysts
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Artivion (NYSE:AORT) in the last three months. The following table encapsulates their recent ...
StockStory.org on MSN2d
Artivion (AORT) Stock Trades Down, Here Is Why
What Happened? Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company ...